Free shipping on all orders over $ 500

DL-Propargylglycine

Cat. No. M11510
DL-Propargylglycine Structure
Synonym:

PAG

Size Price Availability Quantity
200mg USD 120  USD120 In stock
1g USD 220  USD220 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Dl-proparyngine (PAG) is an irreversible inhibitor of cysteine γ -lyase (GCL), a key enzyme involved in glutathione synthesis, regulation of homocysteine concentration and metabolism to sulfur pathway that mediates cysteine synthesis.

Chemical Information
Molecular Weight 113.11
Formula C5H7NO2
CAS Number 64165-64-6
Solubility (25°C) DMSO:10 mg/mL
Storage -20°C
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Beibei Sun, et al. Autoimmunity. DL-propargylglycine administration inhibits TET2 and FOXP3 expression and alleviates symptoms of neonatal Cows' milk allergy in mouse model

[2] Xiufang Zhou, et al. Sleep Breath. DL-Propargylglycine protects against myocardial injury induced by chronic intermittent hypoxia through inhibition of endoplasmic reticulum stress

[3] Nynke R Oosterhuis, et al. Nitric Oxide. DL-propargylglycine reduces blood pressure and renal injury but increases kidney weight in angiotensin-II infused rats

[4] H Kodama, et al. J Neurochem. Cystathionine accumulation in various regions of brain of DL-propargylglycine-treated rats

[5] H Kodama, et al. J Neurochem. Contents of cystathionine and taurine in various cerebellar regions of DL-propargylglycine-treated rats

Related Products
M3554 (anti-GD2 ADC)

M3554 is a novel anti-GD2 ADC designed based on humanized ch14.18 anti-GD2 antibody. M3554 has anti-tumor activity.

OGT2115

OGT2115 is a potent, cell-permeable and orally active heparanase inhibitor with an IC50 of 0.4 μM. OGT2115 has anti-angiogenic properties (IC50 = 1 μM).

DiosMetin 7-O-β-D-Glucuronide

DiosMetin 7-O-β-D-Glucuronide is an antioxidant constituent in the fruits of Luffa cylindrical.

Bendazac L-Lysine

Bendazac L-Lysine is an aldose reductase (AR) inhibitor, which can be used to inhibit the activity of AR in the eye to prevent cataracts.

Ro5-3335

Ro5-3335 acts as an inhibitor of core binding factor (CBF) leukemia. Ro5-3335 is a RUNX1-CBFβ interaction inhibitor that represses RUNX1/CBFB-dependent transactivation.

  Catalog
Abmole Inhibitor Catalog




Keywords: DL-Propargylglycine, PAG supplier, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.